Literature DB >> 33777056

Controlled Human Infection to Speed Up SARS-CoV-2 Vaccine Development.

Marc Baay1, Pieter Neels2.   

Abstract

Entities:  

Keywords:  controlled human infection (CHI); coronavirus; ethics; human challenge; vaccine development

Mesh：

Substances：

Year:  2021        PMID： 33777056      PMCID： PMC7994256          DOI： 10.3389/fimmu.2021.658783

Source DB:  PubMed          Journal:  Front Immunol        ISSN： 1664-3224            Impact factor:   7.561


× No keyword cloud information.
  27 in total

1.  Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?

Authors:  Seán O'Neill McPartlin; Josh Morrison; Abie Rohrig; Charles Weijer
Journal:  BMJ       Date:  2020-11-09

2.  Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans.

Authors:  Robert Frenck; David I Bernstein; Ming Xia; Pengwei Huang; Weiming Zhong; Susan Parker; Michelle Dickey; Monica McNeal; Xi Jiang
Journal:  J Infect Dis       Date:  2012-08-20       Impact factor: 5.226

3.  Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor.

Authors:  Wilbur H Chen; Mitchell B Cohen; Beth D Kirkpatrick; Rebecca C Brady; David Galloway; Marc Gurwith; Robert H Hall; Robert A Kessler; Michael Lock; Douglas Haney; Caroline E Lyon; Marcela F Pasetti; Jakub K Simon; Flora Szabo; Sharon Tennant; Myron M Levine
Journal:  Clin Infect Dis       Date:  2016-03-21       Impact factor: 9.079

4.  Human challenge trials in vaccine development, Rockville, MD, USA, September 28-30, 2017.

Authors:  Marc F D Baay; Thomas L Richie; Pieter Neels
Journal:  Biologicals       Date:  2018-03-21       Impact factor: 1.856

Review 5.  So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development.

Authors:  Christine Grady; Seema Shah; Franklin Miller; Marion Danis; Marie Nicolini; Jorge Ochoa; Holly Taylor; Dave Wendler; Annette Rid
Journal:  Vaccine       Date:  2020-08-11       Impact factor: 3.641

6.  SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.

Authors:  Marc Baay; Pieter Neels
Journal:  Biologicals       Date:  2020-08-15       Impact factor: 1.856

7.  Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.

Authors:  Celina Jin; Malick M Gibani; Maria Moore; Helene B Juel; Elizabeth Jones; James Meiring; Victoria Harris; Jonathan Gardner; Anna Nebykova; Simon A Kerridge; Jennifer Hill; Helena Thomaides-Brears; Christoph J Blohmke; Ly-Mee Yu; Brian Angus; Andrew J Pollard
Journal:  Lancet       Date:  2017-09-28       Impact factor: 79.321

8.  Human Challenge Studies Are Unlikely to Accelerate Coronavirus Vaccine Licensure Due to Ethical and Practical Issues.

Authors:  Stanley M Spinola; Gregory D Zimet; Mary A Ott; Barry P Katz
Journal:  J Infect Dis       Date:  2020-10-01       Impact factor: 5.226

9.  Coronavirus Human Infection Challenge Studies: Assessing Potential Benefits and Risks.

Authors:  Euzebiusz Jamrozik; George S Heriot; Michael J Selgelid
Journal:  J Bioeth Inq       Date:  2020-08-25       Impact factor: 1.352

10.  Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.

Authors:  Noe B Mercado; Roland Zahn; Frank Wegmann; Carolin Loos; Abishek Chandrashekar; Jingyou Yu; Jinyan Liu; Lauren Peter; Katherine McMahan; Lisa H Tostanoski; Xuan He; David R Martinez; Lucy Rutten; Rinke Bos; Danielle van Manen; Jort Vellinga; Jerome Custers; Johannes P Langedijk; Ted Kwaks; Mark J G Bakkers; David Zuijdgeest; Sietske K Rosendahl Huber; Caroline Atyeo; Stephanie Fischinger; John S Burke; Jared Feldman; Blake M Hauser; Timothy M Caradonna; Esther A Bondzie; Gabriel Dagotto; Makda S Gebre; Emily Hoffman; Catherine Jacob-Dolan; Marinela Kirilova; Zhenfeng Li; Zijin Lin; Shant H Mahrokhian; Lori F Maxfield; Felix Nampanya; Ramya Nityanandam; Joseph P Nkolola; Shivani Patel; John D Ventura; Kaylee Verrington; Huahua Wan; Laurent Pessaint; Alex Van Ry; Kelvin Blade; Amanda Strasbaugh; Mehtap Cabus; Renita Brown; Anthony Cook; Serge Zouantchangadou; Elyse Teow; Hanne Andersen; Mark G Lewis; Yongfei Cai; Bing Chen; Aaron G Schmidt; R Keith Reeves; Ralph S Baric; Douglas A Lauffenburger; Galit Alter; Paul Stoffels; Mathai Mammen; Johan Van Hoof; Hanneke Schuitemaker; Dan H Barouch
Journal:  Nature       Date:  2020-07-30       Impact factor: 49.962
View more
  1 in total

Review 1.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.